INS and diabetes mellitus: Previous studies indicated that COX-2 activation might play a pathogenic role in diabetes [32–34], and COX-2 inhibition can protect rat islets from cytokine-induced inhibition of glucose-stimulated insulin secretion [13], implicating the important role of COX-2 in cytokine-mediated β-cell dysfunction and diabetes development.